Newsroom

in the news

21Feb2017
Overcoming the innovation malaise
CenterWatch:: Innovation is often cited as the "key ingredient" by organizations striving to sustain an advantage in the increasingly competitive global marketplace. The pace of technology change is relentless, with those who don't embrace emerging trends often paying a hefty price. Simply "doing the same thing better," however, is not enough.

16Feb2017
How Many Team Members Does It Take To Determine The Study Status?
Clinical Leader:: Sitting on one of those long, painful, study status update calls recently, I was reminded of the famous light bulb joke. You know the one: "How many engineers (lawyers, politicians, etc.) does it take to change a light bulb?" I was both flabbergasted and frustrated that, after 45 minutes, the project manager was still wading through status updates from a myriad of CRO and vendor partners and CRAs — just to figure out where the study was from a site activation and enrollment standpoint.

16Feb2017
Out of Control
International Clinical Trials:: Epidemics like the Ebola virus in 2013 are extremely hard to contain. With the clinical trial process often taking many years to obtain authorisation, new and innovative designs need to be explored to ensure that vaccines can be approved as soon as possible.

14Feb2017
Modeling and Simulation in Clinical Trials: Real Potential or Hype?
Applied Clinical Trials:: Improving experimental drug success rate and accelerating clinical development are top priorities for pharmaceutical companies. Careful decision making during drug development is essential to minimize development time, manage costs and improve the probability of commercial success. Recently, many of the major pharmaceutical companies have begun to explore computer-based bio-simulation strategies to help generate the information necessary to make better decisions.

8Feb2017
Director of Life Sciences Recaps SCOPE 2017
DRI Direct Recruiters Inc:: Aptly named after the legendary Husky (who coincidentally now resides in my hometown), goBalto's mission is to get medicine to patients in need faster by accelerating the time-to-market for new drugs, medical devices, and other therapies. Their SaaS applications offer an end-to-end solution for starting Clinical trials.

1Feb2017
How Patients Will Revolutionize Next-Generation Clinical Research
Life Science Leader:: Often when we think about inefficiencies in the clinical trial process, we focus on the role of the sponsor or CRO, a particular aspect of the value chain, or new technologies that promote data sharing and faster decision making. While these are critical aspects that drive day-to-day operations, there is another aspect of the value chain that we may be neglecting: the patient side.

31Jan2017
First Mover Does Not Always a Market Leader Make
Medium:: No matter your industry, you likely feel intense pressure to get your product or service to market before your competitors. But if that's the first lesson in the Business 101 curriculum, the second should be that achieving "first-mover" status never guarantees success. How can you walk the line between getting to market quickly, but not too quickly? To borrow from Sun Tzu, "If you know the enemy and know yourself, you need not fear the result of a hundred battles."

24Jan2017
Will Special Interests Derail The Future Of Personalized Medicine?
Clinical Leader:: The increasing need for personalized medicine, and resulting demand for companion diagnostics, has led to the integration of the previously separate activities of drug and diagnostic development. The age of precision medicine, with treatments targeted to specific patients based on a companion test identifying the need for such a treatment, is upon us.

20Jan2017
Are Clinical Trial Matching Services Truly Patient-Centric?
Applied Clinical Trials:: If you have ever tried to find the right clinical trial for yourself or a loved one, you know the process can be confusing and challenging. Recognizing the need for alignment, several so-called clinical trial to patient matching services have emerged. Though well-intentioned, some of the current formats adopted by these service providers may inadvertently be introducing additional complexity into the lives of patients looking for life saving therapies.

18Jan2017
To you it's a document; to me it's my life
PharmaPhorum:: Proactive and included patients can help clinical trial retention as well as providing more accurate results. Jae Chung relates the story of one cancer patient who took the initiative to ensure his treatment went ahead.

9Jan2017
Moving Beyond Clinical and Operational Metrics in Study Startup
CenterWatch:: Metrics are central to efforts to rein in clinical trials that are either poorly initiated or have incurred unforeseen events, which place the original timelines and/or budgets at risk of overages. They also drive competitive performance among those organizations performing trials.

21Dec2016
Drug Discovery & Development's Top 7 Stories of 2016
Drug Discovery & Development:: Drug Discovery & Development has rounded up our most popular stories of 2016. These articles provide a snapshot of the change the pharmaceutical industry experienced throughout the year.

21Dec2016
Top 10 of 2016
Clinical Leader:: Clinical Leader set multiple monthly website traffic records. For the year, we recorded more visits than any point since we launched five years ago. The Clinical Leader editorial board also added several passionate experts to our distinguished list of clinical professionals. Here are our Top 10 lists for 2016, organized by article type.

16Dec2016
Accelerating Innovation to Cut Drug Prices
The Huffington Post:: Americans spend a staggering amount of money for prescription drugs, and the prices keep rising. Cases of corporate greed like the infamous Martin Shkreli, former CEO of Turing Pharmaceuticals who increased the price of the life-saving medication Daraprim by 5,000 percent, have become the public face of the entire industry. That's unfortunate because it's grossly unfair to paint all drug manufacturers with such a broad brush. However, the industry does need to take it upon itself to overhaul a research and development process hamstrung by clinical trials that drag on for years and cost billions of dollars.

8Dec2016
Novartis Approach Slashes Study Startup Time
Clinical Leader:: If the scientific rationale seems rather complicated, then the trial may need a scientific review committee in addition to the IRB. Each one of those reviews could take a month or more. Petrone notes goBalto has a solution that can make cycle-time transparent. While the solution may not change cycle-times, it will allow companies to see what processes are taking the longest. With that insight, sponsors can start to examine what can be done to shorten them.

1Dec2016
Why is there such Inefficiency in Site Selection?
CenterWatch:: This question is often asked about an industry deeply rooted in paper-based, spreadsheet tools for clinical trial conduct. Study teams have continued to rely on these older tools and relationships with principal investigators that have developed over time to select sites, building an institutional knowledge about specific sites based on previous studies.

20Nov2016
Barriers to Increased Participation of Minorities in Clinical Trials
Pharmaceutical Outsourcing:: Clinical trials are at the heart of the process for bringing new medicines to patients. One of the most critical aspects to the conduct of any clinical trial is identifying the right group of people to include in the study. Unfortunately, many of the clinical trials conducted in the United States suffer from a lack of diversity, with minority populations being consistently underrepresented.

18Nov2016
Could Gamification Improve Clinical Trials?
Applied Clinical Trials:: The gamification of many aspects of our culture is well under way, and some researchers are even beginning to consider the integration of gamification principles into clinical trials. In the context of clinical trials, gamification presents an excellent opportunity to improve performance and reduce costs.

26Oct2016
Are Delays in Clinical Trials Due to a Lack of Experienced CRAs?
Drug Discovery & Development:: In an industry plagued by rising development costs and increasing complexities, to what extent is the CRA shortage to blame for the delays in clinical trials? It is fair to say that it is a contributing factor, but it is equally important to point out that well documented bottlenecks in starting clinical trials, such as, protocol amendments, contract and budget negotiations, IRB approvals, and others, contribute to significant trial delays and these are not the primary responsibility of the CRA.

19Oct2016
10 Tips for Enabling Better CRO-Sponsor Collaborations
MasterControl GXP Lifeline:: By 2020 72% of clinical trials are anticipated to be outsourced, up from just 23% in 2012. Sponsors are seeking cost reductions, access to specialized knowledge, and increased speed and agility. Meanwhile, CROs focus is on business goals related to economic outcomes for their owners, investors and shareholders. Each group is expecting deliverables and timelines to be met or exceeded for potentially different business reasons, leading to a traditional client/vendor-type relationship.

11Oct2016
CRO-Sponsor Partnerships
Contract Pharma:: The reality is that the sponsor-CRO relationship is not always a win-win. While sponsors are clearly enticed by the efficiencies that can be gained through CRO use — a recent report from ISR projects that the CRO industry will grow at a rate of 7.4% CAGR through 2019 - there is nonetheless a downside to the relationship.

22Sep2016
Fighting the Commoditization of Sites: It Starts with the Site Initiation Visit
Bioscience Technology:: One of the biggest factors contributing to lengthy cycle times is the inability of sponsors and Contract Research Organizations (CROs) to engage investigative sites in a manner that supports effective patient recruitment and retention in the context of a swift budget and contract process. In this mentality, the site is treated less like a valued partner and more like a commodity in the clinical research lifecycle. Want to move towards better engagement models? It starts with the Site Initiation Visit (SIV), a critical event that sets the stage for an open, collaborative relationship to last throughout the study.

16Sep2016
Eliminating the Three Evil "E's" in Starting Clinical Trials
Applied Clinical Trials:: In an effort to confront the oft-mentioned costs of drug development, the clinical trials industry has been evolving from its slow paper-based methods and standalone spreadsheets towards automated, cloud-based systems. There has always been a strong focus on study conduct and quality. But as stakeholders are increasingly aware that better study startup (SSU) processes are linked to shorter clinical timelines, the emphasis is shifting in that direction.

15Sep2016
Managing Clinical Trial Complexity
Advance for Health Information Professionals:: While most of the industry's risk management efforts have focused on post-marketing drug safety, the clinical trial process holds a broad array of other potential risks that could jeopardize a company's multi-million-dollar product development investment-risks such as site staffing shortages, patient recruitment issues, logistical problems with drug supplies, or regulatory delays. Risk management in clinical operations really starts with effective project management.

15Sep2016
PSI selects goBalto's site ID cloud-based software to speed up trials
Outsourcing-Pharma.com:: The Swiss contract research organization (CRO) has chosen goBalto's end-to-end solution to assist with site identification, feasibility assessment and selection for sites for the study.

13Sep2016
The Struggle To Speed Study Start-up
Clinical Informatics News:: Recent research conducted by Tufts Center for the Study of Drug Development (CSDD) has found that clinical research organizations (CROs) face an increasingly complex and competitive environment in which to administer clinical trials. Study start-up, in particular, can be a drawn-out process that, depending on the protocol, budget negotiations, and availability of patients, can last anywhere from a few months to a full year. CROs are therefore looking for strategies, whether in the form of tools or processes — often a combination of both — to streamline this complicated phase.

18Aug2016
10 Tips for Enabling Better CRO-Sponsor Collaborations
CenterWatch:: By 2020 72% of clinical trials are anticipated to be outsourced, up from just 23% in 2012. Sponsors are seeking cost reductions, access to specialized knowledge, and increased speed and agility. Meanwhile, CROs focus is on business goals related to economic outcomes for their owners, investors and shareholders. Each group is expecting deliverables and timelines to be met or exceeded for potentially different business reasons, leading to a traditional client/vendor-type relationship.

5Aug2016
Assessing Practices & Inefficiencies with Site Selection, Study Start-Up, and Site Activation
Applied Clinical Trials:: Sponsor and contract research organization (CRO) companies conducting global clinical trials face numerous operational and logistical challenges. With more than 3,000 active global clinical trials conducted annually at approximately 40,000 investigative sites dispersed worldwide, companies are looking for more efficient ways to streamline their processes in order to speed up timelines.

5Aug2016
Concomitant medications in clinical trials: Why the stakes are high
PharmaLive:: Almost every reported concomitant medication has a reason – and many, if not all of these reasons should be reported as adverse events. Concomitant medications (a.k.a., con-meds) are other prescription medications, over-the-counter (OTC) drugs or dietary supplements that a study participant takes in addition to the drug under investigation.

3Aug2016
Removing the Blinders in Site Selection
Advance for Health Information Professionals:: One of the most difficult aspects [of clinical trials] is the selection of the right sites by sponsors and contract research organizations (CROs), who often lack a transparent, evidence-based strategy for this task. Instead, they frequently rely on archaic paper-based or spreadsheet methods to identify sites across the globe with a reasonable chance of enrolling the contracted number of patients on schedule, and the ability to generate quality data.

1Aug2016
How-To Guide
International Clinical Trials:: Standard operating procedures (SOPs) rarely grab the spotlight like transformational technologies or newer strategies, such as risk-based monitoring or Quality by Design. But SOPs deserve some love. With their coveted goal of improving operational efficiency, they have long been fundamental to many industries, and the clinical trials sector is no exception.

22Jul2016
SmartViews: The unsexy plumbing of clinical trials
PharmaTimes:: There is no doubt that clinical research is critical to advancing medicine and public health. Clinical trials play an essential role in drug development by effectively demonstrating the efficacy and safety of a pharmaceutical compound, yet they are not for the faint of heart. Conducting even one is a monumental, complex and resource-intensive endeavour that relies on a multitude of stakeholders, workflows, processes and information systems.

21Jul2016
Co-Opting Innovation: How Startups and Big Companies Together Accelerate Innovation
CIOReview:: The race to innovate is increasingly a top priority for businesses across all sectors. The fact is that only a tiny percentage of companies will prevail.

12Jul2016
Virtual Clinical Trials: The Future of Patient Engagement?
Applied Clinical Trials:: Virtual clinical trials represent a relatively new method of collecting safety and efficacy data from clinical trial participants, from study start-up through execution to follow-up. These trials take full advantage of technologies (apps, monitoring devices, etc.) and online social engagement platforms to conduct each stage of the clinical trial from the comfort of the patients home—including recruitment, informed consent, patient counseling, through to measuring clinical endpoints and adverse reactions.

30Jun2016
DevOps is slowly taking over the IT landscape
TechTarget:: IT teams—from 50-year-old companies migrating apps off the mainframe to stateless cloud-native DevOps adherents—are investigating infrastructure automation via Ansible.

28June2016
It's Site Selection, Not a Toss of the Dice
Clinical Informatics News:: Conducting clinical trials is a high stakes game, but disturbingly, the risk of selecting non-performing or underperforming investigative sites is greater than losing at the gambling table.

25May2016
Making Site Selection Precise And Accurate
Clinical Leader:: Underperforming investigative sites have long been a puzzling issue for clinical trial stakeholders. There are lots of reasons for sub-optimal performance, ranging from inadequate processes for study execution to overly complex protocols. Current thinking suggests that at least some of the problem stems from continued reliance by many sites on paper-based or simple spreadsheet methods for numerous aspects of study conduct.

20May2016
Disruptive Technologies: Breaking Down Barriers to Drug Development
Applied Clinical Trials:: Many factors contribute to the increasing challenges and costs of developing medicines, including more complex disease targets, increasing regulatory requirements, larger clinical trial sizes, and greater focus on targeting chronic and degenerative diseases. Companies are exploring ways to reduce development times and increase the odds of success using new research models, adaptive clinical trial designs and methodologies, eClinical tools, innovative approaches to patient recruitment, and automated techniques for analyzing data. Still, challenges remain.

16May2016
The Cloud: speeding drug delivery
DisruptiveViews:: By playing a critical role in enabling digital transformation, cloud computing lowers typical IT barriers of slow time to value, risky implementations, limited resources, heavy maintenance, and incompatible systems. Allowing cloud computing to free up resources to run the business enables organizations to focus their time and energy on the pursuit of innovation and growth.

16May2016
Getz: Site Activations Hurt By Commodity Mentality
Clinical Leader:: Site activation in clinical trials is not an efficient process. Those inefficiencies delay the start of trials and are costly to sponsors, CROs, and sites. But more importantly, they keep medicines from getting to patients in a timely manner. Many of the issues are ones that investigative sites have been vocalizing for some time, but which sponsors and CROs have been slow to hear.

10May2016
Breakthroughs in Clinical Trials Utilizing the Power of the Cloud
CloudTweaks:: Inefficiencies in the clinical trials process continue to stymie industry stakeholders anxious to rein in the cost of product development and adhere to tighter timelines. There is an urgent need to expedite the time-to-market for new drugs and to make the approval process simpler. Discontent with the 'status quo' and dismal performance metrics are driving a cacophony of infrastructural changes with stakeholders embracing technologies that are finally moving the needle.

09May2016
Innovation Detractors in Pharma
Bioscience Technology:: Innovation is a critical ingredient for companies striving to sustain an advantage in the increasingly competitive global marketplace. Simply "doing the same thing better" is not enough. Across multiple industries, companies are focusing their top teams on leveraging social, mobile, analytics, and cloud to implement "disruptive" technologies designed to promote innovation and transform the enterprise. And while many industries are blazing new trails in pursuit of new technologies, pharma appears to be lagging behind, often adopting a watch and wait approach.

22Apr2016
Addressing The Challenges Associated With Site Selection For Clinical Trials
xTalks:: Planning for and conducting a clinical trial presents many challenges associated with study design, patient safety and outcome determination. With growing pressure from stakeholders to speed the process of drug development, and increasing demand from regulators to submit compelling data, it’s easy for clinical trial coordinators to lose sight of one of the most important aspects of the process: study startup.

01Apr2016
Refocusing on Risk Mitigation in Starting Clinical Trials
The CenterWatch Monthly:: Site selection, traditionally manually intensive, is a critical step in getting clinical trials off to a good start, yet poorly performing sites have long been a tough challenge for the industry.

31Mar2016
'Paradigm shift needed' in trial site selection process
Outsourcing-Pharma.com:: goBalto has launched a trial site scoring system it claims will improve site selection by taking a data-driven approach. The new solution, called Select, provides sponsors and CROs with a data-driven approach to weighing selection and performance variables to aid in identifying sites and target populations ideally suited to their studies.

31Mar2016
goBalto Optimizing Clinical Studies
CIOReview:: Pharmaceutical companies are constantly looking to innovate and perform business operations in smarter ways, as the costs of drug development have continued to escalate. It is a race against time to develop drugs that save lives and ease suffering. And while the healthcare industry has made tremendous strides, an area that remains frustratingly slow are the clinical trial.

02Mar2016
Utilization of the Crowd for Medical Research
Bioscience Technology:: The concept of using the crowd as a resource for funds and ideas has made major inroads into modern society, being utilized in such diverse fields as journalism, law enforcement, product design, graphic design, architecture, and much more. Recently, some have begun to explore the utilization of the crowd for various purposes in medical research, including fundraising as well as crowdsourcing for intellectual analyses and insights.

01Mar2016
Life saver
PharmaTimes:: As clinical trials grow ever more complex, there are steps companies can take to keep their studies on track and on target.

29Feb2016
Rethinking "Patient Centricity": Using Technologies to Distribute Clinical Trial Results Direct to Patient
IEEE LifeSciences:: The drug development community is increasingly turning to patient engagement or "patient centricity" approaches to optimize clinical trials costs and improve research outcomes. The active participation of patients in clinical research can potentially lead to improvements in the credibility of results, higher rates of enrollment and retention, and ultimately, lower trial costs.

20Feb2016
Time For Business Intelligence in Study Startup
BioPortfolio:: The clinical trials sector is heavily invested in technologies that track how studies unfold, but putting that information to good use requires real-time visibility actionable data.

19Feb2016
Better Study Startup Means Less Study Rescue
Pharmaceutical Compliance Monitor:: When a clinical trial does not unfold as planned, it may be heading for rescue. Communication problems among stakeholders, patient enrollment delays, overly complex protocols, and poor site compliance are just a few of the many reasons why rescue action is needed.

11Feb2016
Risk Mitigation Pivotal to Starting Clinical Trials
Drug Discovery & Development:: While risk management efforts in drug development have focused mostly on post-marketing drug safety, the clinical trials process has its own mix of potential risks just waiting to derail a company's high-dollar development programs.

01Feb2016
Reflections and Predictions
PharmaVOICE.com:: PharmaVOICE celebrates 15 years of trends with a look back at the market forces that have defined the industry and what's ahead as the healthcare ecosystem continues to be reinvented.

11Jan2016
The Achilles Heel of Clinical Study Startup—Bottlenecks
Clinical Leader:: The clinical trial phase of a drug development program is by far the most costly, risky, and protracted phase of the investigative process. Over the past decade, the capitalized cost to develop an approved new drug has more than doubled to $2.6B, with the approval rate for drugs entering clinical development dropping to less than 12 percent. The first step towards reducing cycle times and costs involved in conducting clinical research is the identification of bottlenecks.

06Jan2016
A Guide to Risk-Based Study Startup: Using big data to overcome cumbersome study-start up processes
Applied Clinical Trials:: The process of initiating clinical trials is cumbersome, challenging and fraught with delays—it has the greatest impact on patient recruitment, trial duration and its associated costs, unfortunately, it is also the worst performing stage of any clinical trial. Study startup is the most resource- and labor-intensive period in a study's life cycle after data cleaning and database lock activities. Any increase of duration or responsibilities during startup has an increased logistical and financial impact.

01Jan2016
Big Data Barriers in Healthcare
Advance for Health Information Professionals:: In healthcare, harnessing and unlocking the potential in existing data sources, including clinical trials, biomedical imaging studies, EHRs, genomic and personal health data, can provide insights to improve decision making in all aspects of clinical trial design and drug development.

15Dec2015
PM360 Innovators 2015: Products
PM360:: PM360's Innovations Issue, established four years ago, serves as a comprehensive guide to our readers, providing a glimpse at the year's most cutting-edge: Companies, Divisions, Startups, Products, Services and Strategies.

11Dec2015
goBalto lands global site activation software deal with ICON
FierceBiotechIT:: goBalto has landed a deal with ICON that will see its site activation software used across all of the CRO's global studies. The agreement gives ICON another tool with which to shorten study startup times, potentially helping it to accelerate the rate at which it burns through its backlog of bookings.

10Dec2015
goBalto goes for Speed by Reducing Manual Processes in Study Startups
Outsourcing-Pharma.com:: A focus on study startup can reduce cycle times, mitigate risks, and ultimately eliminate operational bottlenecks, which can result in delays or derailment of clinical trials—it is the key to accelerating clinical trials, reducing costs, and speeding the availability of therapies to patients.

17Nov2015
Bringing Transparency and Collaboration to CRO Oversight
Contract Pharma:: The connection between sponsors and contract research organizations (CROs) is strengthening as outsourcing continues to be a clinical trial mainstay. Making the relationship between the sponsor and the CRO as productive as possible means acknowledging the ongoing transition away from tactical projects and toward strategic partnerships, with both stakeholders having a vested interest.

16Nov2015
Speeding Study Startup Through Better Collaboration and Data Flow
Clinical Informatics News:: A critical question facing many sponsors and contract research organizations (CROs) is whether another system to support study startup (SSU) is really needed. It's a fair question in the clinical world where the urgent need for better execution of clinical trials has led to a proliferation of technologies, namely the clinical trial management system (CTMS); the electronic trial master file (eTMF); electronic data capture (EDC); and others. Each of these solutions focuses on specific pieces of the clinical trial continuum, yet, they overlook aspects unique to SSU, a complex process that continues to stumble and stall clinical trial timelines.

09Nov2015
Accelerating Clinical Trials
Advance for Health Information Professionals:: With thousands of investigational pharmaceuticals, biologics and medical devices in clinical trials, there is constant, intense pressure to bring promising candidates to market as soon as possible. As seriously ill patients worldwide wait for these new therapies, complicated study protocols, globalization and paper-based methods of conducting trials continue to delay market entry.

09Nov2015
Stumbling Seven Times but Recovering Eight
Applied Clinical Trials:: Insights for Pharma Executives Sourcing Global Clinical Trials in the U.S. and Japan
Though a highly attractive market, historically Japan has been insular—a consequence of a number of factors, such as medical culture and the complexity of the underlying regulatory context. One of the nuances of this environment was the so-called "drug-lag," where new drug approvals could lag up to six years behind U.S. and European Union (EU) approval. Because of these delays, companies often didn't bother to pursue drug development.

05Nov2015
BI the Way
International Clinical Trials:: The clinical trials sector is heavily invested in technologies that track how studies unfold, but putting that information to good use requires turning real-time visibility into actionable data. It is not enough for a sponsor to know that one site enrols quicker or is speedier than others at turning around the study budget. Instead, it is more effective to understand what it takes for all sites to complete those tasks in a timely manner and where the bottlenecks are, so steps can be taken to turn more sites into high achievers.

02Nov2015
Study Startup: New Battleground in CRO Differentiation Strategy
Drug Discovery & Development:: With the CRO market approaching tipping point, forward-thinking CROs are looking to differentiate themselves as competition stiffens. Differentiation is an opportunity for CROs as they move away from commoditized, tactical service offerings emphasizing lowest price, in favor of becoming risk-sharing strategic partners in the race for faster and higher quality clinical trials. At a time when study startup (SSU) remains a perpetual bottleneck, CROs that embrace solutions that confront this challenge may be positioning themselves as a step ahead of the competition.

01Nov2015
How Much Transparency Is Too Much With Clinical Trials?
Life Science Leader:: There is a growing movement by some researchers and regulators to increase disclosure of clinical trial results. According to advocates, the push for greater transparency would result in the publication of all clinical trial results, including those currently under investigation, as well as past trials conducted. In response, several pharmaceutical companies have publically embraced the concept of clinical trial transparency, notably AstraZeneca with the recent creation of a Scientific Review Board to independently assess requests for data.

26Oct2015
Three Questions
The CenterWatch Monthly:: Q. As head of goBalto, a developer of cloud-based programs that accelerate clinical study startup, what specific steps can CROs take to lower startup expenses today that were not available 10 years ago and why is oversight such a hot topic with sponsors now?

01Oct2015
goBalto making tracks with platform adoption
DDNews:: goBalto touts a variety of ways in which its Activate service can support CROs, including data sharing, improving quality and reducing cycle time by 66 percent. The company asserts on its website that the Activate platform can help lower the average cycle time for CROs to complete registration documents from an average of 35 days to just 14. Activate also allows organizations to automate workflows to alert for and track when submissions are due, and offers workflow templates to help define the regulatory documents and submissions required for more than 60 countries.

11Aug2015
Q&A: Mush, you huskies!
DDNews:: Editor interview with goBalto's CEO Sujay Jadhav.

15Jul2015
Expediting Study Startup Across The Globe
Applied Clinical Trials:: The need for more efficient clinical trials is driving greater use of cloud-based solutions, especially with the rise in globalization, a trend that is seeing participating sites venturing full force into regions such as Eastern Europe, Latin America and Asian countries. But this opportunity is not without its challenges. Conducting clinical trials in places with unfamiliar regulatory pathways, cultural differences, and limited infrastructure is highlighting the value of technology that streamlines a key bottleneck—study startup—allowing stakeholders to better adhere to established timelines and budgets.

13Jul2015
Bringing Speed to Study Startup
Drug Discovery & Development:: There is intense pressure to speed clinical trials and restrain costs, but inefficiencies tied to complicated protocols, globalization, and paper-based methods have stalled these efforts. The current status of clinical trials has encouraged stakeholders to embrace cloud-based solutions such as clinical trial management systems (CTMS), and the electronic trial master file (eTMF), but one key bottleneck, study startup (SSU), has been largely overlooked.

09Jul2015
The Need For Speed In Clinical Study Startup
Outsourced Pharma:: The status of clinical trials continues to stymie industry stakeholders anxious to rein in the cost of product development and adhere to tighter timelines. Despite intense pressure to speed development, mounting evidence documents ongoing inefficiencies tied to complicated protocols, globalization, and old-school paper-based processes, driving clinical stakeholders to embrace technologies that are finally moving the needle.

15June2015
The Achilles Heel of Clinical Trial Study Startup—Bottlenecks
Biospace:: Over the past decade the capitalized cost to develop an approved new drug has more than doubled from $1,044M in 2003 to $2,558M in 2013 (source: CSDD, 2015), and although some have labeled this as publicized propaganda....

13Apr2015
Speeding Clinical Trials Through eClinical Systems
Applied Clinical Trials:: Testing the safety and efficacy of new drugs is a costly and complex process for pharmaceutical organizations. The rising cost and complexity compromises....

16Mar2015
At SCOPE 2015, goBalto unveils results of rapid company growth
Clinical Informatics News:: goBalto spent 2014 enhancing its products, automating processes, and investing in customer support and infrastructure....

05Mar2015
goBalto looks at ways to speed up clinical trial setup
MedCityNews:: goBalto uses its recent fundraise to speed up not only clinical study startup, but also other aspects of clinical trials, including patient recruitment....

29Jan2015
Using Technology to Improve Study Startup
Contract Pharma:: The 1980s saw an escalation in the number of CROs serving global biopharmaceutical companies. In its initial uses, technology always focused on the clinical study conduct phase....

15Dec2014
Predictions for 2015: Trends in Clinical Trial Processes
Applied Clinical Trials:: The current pressure on sponsors and contract research organizations (CROs) to execute clinical trials quickly and effectively is on the increase....

21Nov2014
Ed Miseta interviews goBalto's Sandi Freeman on how technology will impact clinical trials in 2015
Clinical Leader:: As a new guard comes along and people become more confident with electronic solutions, the reliance on paper-based clinical trial processes may finally be shifting....

19Sept2014
Sandi Freeman discusses trusted collaboration with Pharmaceutical Compliance Monitor
Pharma Compliance Monitor:: Although there are obvious benefits to outsourcing, it creates new challenges around quality, oversight, collaboration, and governance....

14Jan2014
goBalto spreads its wings in Singapore, UK
PharmaTimes Online:: goBalto, the US-headquartered provider of cloud-based solutions to faciltiate clinical-trial start-ups and workflows, is expanding its international reach with new locations in Singapore and the UK....

25Feb2013
Fierce's Top 10 Biotech Techies - 2013
FierceBioIT:: Read the profiles in our second annual "Top 10 Biotech Techies" report and you'll see what this term means to us - people who combine the best of high technology and biotechnology to solve major problems in healthcare....

23Jan2013
goBalto wants to save Big Pharma from bungling one big thing
Fierce BioTechIT:: Huge and scary numbers accompany the costs of drug development, including a study last year in Forbes that averaged the total spending per new med from several top pharma groups at $4 billion. Yikes. Behind that ...

28Dec2012
goBalto Raises $12M Series B for Cloud-Based Clinical Trials Software
Dow Jones:: goBalto Inc., which makes cloud-based software to simplify clinical trials for pharmaceutical companies and research organizations, has raised a $12 million Series B round...

28Dec2012
The Daily Startup: With Big Rivals, goBalto Gets Richer
Wall Street Journal:: goBalto, which makes cloud-based software to simplify clinical trials for pharmaceutical companies and...

30Mar2012
goBalto Receives ’Special Recognition’ Award
Partnerships in Clinical Trials:: The 2nd Annual Partnerships in Clinical Trials Awards took place in March 2012 where the conference honored some of the valued members of the clinical trials community. Congratulations to all of our winners!

03Nov2011
Innovation needed to kick-start eClinical sector; goBalto
Outsourcing Pharma.com:: A "tectonic shift" will kick-start eClinical innovation and move the sector beyond...

01Apr2011
goBalto Study Startup
ClinPage:: In the unofficial design manual for clinical trial software programs, there are numerous unwritten rules but only a single severe commandment...

29Mar2011
goBalto’s Three Easy Steps to Study Startup
Bio-IT World:: Online portal goBalto.com is about to formally launch Tracker, the industry’s first web-based platform devoted to clinical study startup, inspired by the user-friendly “look and feel” of consumer-facing outfits like Amazon.com, Salesforce, and Facebook.

07Oct2010
Inside San Francisco based - Pivotal Labs, the Agile Force Behind Twitter, Groupon, Gowalla and goBalto
GigaOM:: Pivotal Labs is a name that comes up often in regards to web startups, but it’s sort of an enigma. The company’s San Francisco office is home to the hyped-up distributed social networking effort Diaspora; its work has been credited for shaping Twitter’s development culture; and its clients include Groupon, Gowalla and Best Buy’s “Remix” API project. But what exactly does Pivotal Labs do?

05Aug2010
goBalto Grows Matchmaking Portal
GigaOM:: The online portal goBalto.com is the quintessential Silicon Valley start-up, run by eight passionate, mostly 20-something big business types with the entrepreneurial charm to attract capital and the litheness to adopt new ideas quickly. The latter trait allowed goBalto to radically shift direction last December, after joining Eric Ries’ Lean Startup crusade to build new companies by better engaging customers.

22Apr2010
Winners of the 2010 Best Practices Program
Bio-IT World:: Bio-IT World has just announced the winners of its sixth Best Practices Awards program. Grand Prize winners from six life sciences awards categories were Bristol-Myers Squibb, The Scripps Research Institute, PROOF / iCAPTURE Centre of Excellence, Massachusetts Institute of Technology, Centocor R&D, and FDA. The competition’s second Judges’ Prize was awarded to goBalto.com...

01Feb2010
The Matchmaking Market
The Scientist:: Last August, Kunhua Chen, CEO at Exon Biosystems—a San Diego–based contract research organization (CRO) specializing in protein services—got a request from Elan Pharmaceuticals for a quote to sequence 14 antibodies. Recognizing the fit between his company’s abilities and the requested work, he responded right away. Two weeks later he got an email that Elan was ready to order. A month after that, he struck a deal for $80,000—the biggest project in the company’s three and a half year history.

01Sep2009
goBalto adds sites in “high growth” Latin American market
Outsourcing Pharma.com:: Drug development partnering site goBalto’s addition of Latin American clinical sites to its database in a deal with Chilean CRO Clinical Trials Support (CTS) is timely given the pharma and biotech industry’s focus on emerging markets.

27Aug2009
10 Promising Companies Selected as Finalists to Present to Leading Investors at LifeScienceFest 2009
Business Wire:: More than 120 of the medical device and life science industry’s top investors, innovators and executives will gather on September 9, 2009 in Menlo Park as we showcase promising early stage innovations from medical devices, diagnostics and bio-informatics.

26Aug2009
Clinical Trials Support adds Latin American sites to goBalto
PharmaTimes Online:: More than 950 investigator sites and hospitals in Latin America have been added to goBalto, the online partnering site for the pharmaceutical development and manufacturing sectors.

24Aug2009
goBalto Drug Development Partnering WebSite to Include Clinical Trials Support’s List of Investigator Sites
PRWeb:: goBalto, an online drug development partnering site for the pharmaceutical development and drug manufacturing industry, announced today that Clinical Trials Support is making its proprietary list of over 950 Latin American-based Investigator Sites and hospitals available on goBalto.com.

24Aug2009
Sponsors Run to goBalto.com to Size Up Service Providers
eCliniqua:: A newly launched website—goBalto.com—is providing the drug development industry with unprecedented intelligence about their would-be partners around the world.

05Aug2009
Contract research on the rise
TheScientist:: The global economic crisis has got most businesses pinching pennies just to stay afloat, and the drug development industry is no exception. But at least one sector of the biotechnology sector -- contract research organizations (CROs) -- is on the rise.

21Jul2009
PharmaView: Pharma CMOs, Meet Web 2.0
PharmaManufacturing.com:: How do you rate? With goBalto, your clients can tell all. One of the virtues of the Internet age is that you need never shop uninformed. In the market for a car? Educate on Edmunds. An electrician? Angie’s List. A book, a board game? Ask Amazon.

23Jun2009
goBalto Partners with Pharma Services Network to Help Sponsors Evaluate Leading CROs
PRWeb:: SAN FRANCISCO, CA – June 23, 2009 – goBalto, a professional social networking site for the pharmaceutical development and drug manufacturing industry, announced today that Pharma Services Network is making its proprietary list of Clinical Research Organizations (CROs) available on goBalto.com.

27May2009
ChinaBio Names Official Partners for Partnering Forum in Shanghai
Reuters:: The ChinaBio Partnering Forum to be held on June 23-24, 2009, in Shanghai, has announced its Official Partners for the event: BayHelix, BioCentury Publishing, BusinessWire, goBalto.com, GVA Kidder Matthews, Nature Publishing Group and OneMedPlace.

26May2009
goBalto sets up website for Pharma industry
Manufacturing Chemist:: US-based goBalto has set up a website at www.gobalto.com to enable drug-development companies to find partners, share knowledge, and discover opportunities.

20May2009
Maya Clinicals partnership extends goBalto site reach to India
PharmaTimes Online:: The roster of more than 7,000 service providers on goBalto, an online drug development partnering site launched just last month, has now expanded to include investigator sites and hospitals in India, through a partnership with locally active contract research organisation (CRO) Maya Clinicals.

19May2009
goBalto Partners with Maya Clinicals to Expand Bio-Medicine:: Its List of Investigator Sites
goBalto, an online drug development partnering site for the pharmaceutical development and drug manufacturing industry, announced today that Maya Clinicals is making its proprietary list of India-based Investigator Sites and hospitals available on goBalto.com.

06May2009
goBalto adds ChinaBio’s list of contract research organisations to website
Manufacturing Chemist:: US-based goBalto, a website that enables drug development companies to find partners, share knowledge and discover opportunities, has put ChinaBio’s proprietary list of more than 260 China-based contract research organisations (CROs) and contract manufacturing organisations (CMOs) up on the site.

03May2009
More on China Biotech Deals: M&A Numbers Misleading
Seeking Alpha:: ChinaBio® LLC agreed to publish its proprietary list of over 260 China-based Contract Research Organizations (CROs) and Contract Manufacturing Organizations (CMOs) on goBalto.com.

01May2009
goBalto, Inc. Partners With ChinaBio to Expand Its List of Contract Research Organizations
BioSPace:: goBalto, an online drug development partnering site for the pharmaceutical development and drug manufacturing industry, announced today that ChinaBio(R) LLC is making its proprietary list of over 260 China-based Contract Research Organizations (CROs) and Contract Manufacturing Organizations (CMOs) available on goBalto.com. goBalto recently launched their web-based platform that enables members to quickly and efficiently find partners, share knowledge and discover opportunities.

30Apr2009
ChinaBio® Publishes Proprietary China CRO/CMO List on goBalto
ChinaBio Today:: ChinaBio® LLC is making its proprietary list of over 260 China-based Contract Research Organizations (CROs) and Contract Manufacturing Organizations (CMOs) available on goBalto.com.

30Apr2009
goBalto Partners With ChinaBio to Expand Its List of Contract Research Organizations
San Francisco Business Times:: goBalto, an online drug development partnering site for the pharmaceutical development and drug manufacturing industry, announced today that ChinaBio(R) LLC is making its proprietary list of over 260 China-based Contract Research Organizations (CROs) and Contract Manufacturing Organizations (CMOs) available on goBalto.com.

22Apr2009
Jae Chung, Co-Founder and CEO of goBalto, Unveils New Web-Based Platform
McKinsey and Company:: Jae Chung (SEO 00-02), CEO and co-founder of goBalto, a dedicated online drug development partnering site for the pharmaceutical and drug manufacturing industry, has unveiled the company's new web-based platform and website, goBalto.com.

18Dec2008
Brand design for a pharmaceutical industry game changer
Jae Chung came to Hot Studio this Fall with a bold new business idea for changing the way pharmaceutical companies find, evaluate, and collaborate with qualified partners.

Load More

press releases

October 17, 2016

goBalto Study Startup Summit Attracts Leading Pharmaceutical and CRO Organizations

Engagement reflects adoption of industry proven study startup solutions

SAN FRANCISCO, October 17, 2016 -- goBalto, Inc., the leading provider of cloud-based clinical study startup solutions, announced today continued growth in attendance at its biannual Study Startup Summit meetings by leading pharmaceutical and CRO organizations.

September 13, 2016

PSI CRO Adopts goBalto's End-to-End Study Startup Platform for Clinical Trials

Speeding trial deployments from site identification to activation, while ensuring regulatory compliance

SAN FRANCISCO, September 13, 2016 -- goBalto, Inc., the leading provider of cloud-based clinical study startup solutions, announced today that PSI CRO has chosen goBalto's complete end-to-end platform for starting clinical trials, from site identification, feasibility and selection, through to activation, with comprehensive metrics to track adherence to timelines and budget.

August 30, 2016

CMIC HOLDINGS, a Leading CRO in Asia Implements goBalto Activate to Accelerate Study Startup

International expansion reinforces goBalto's leadership position

SAN FRANCISCO, August 30, 2016 -- goBalto, Inc., the leading provider of cloud-based clinical study startup solutions, announced today that CMIC HOLDINGS has chosen goBalto to further bolster CMIC HOLDINGS' clinical study startup process throughout Asia.

August 18, 2016

Benchmark Study Assessing Study Startup Published in Applied Clinical Trials

Research focused on assessing practices and inefficiencies associated with site selection and activation

SAN FRANCISCO, August 18, 2016 -- goBalto, Inc., the leading provider of cloud-based clinical study startup solutions, announced today the publication of the peer-reviewed article 'Assessing Practices & Inefficiencies with Site Selection, Study Start-Up, and Site Activation' in Applied Clinical Trials, a study conducted in collaboration with the Tufts Center for the Study of Drug Development (CSDD).

April 07, 2016

goBalto Awarded Top 20 Most Promising Biotech Technology Solution Providers by CIOReview Magazine

Industry proven study startup process optimization key to selection

SAN FRANCISCO, April 7, 2016 -- goBalto, Inc., the leading provider of cloud-based clinical study startup solutions, joins an elite number of companies that have earned a spot on the 20 Most Promising Biotech Technology Solution Providers list of 2016 by CIOReview Magazine.

March 31, 2016

goBalto Delivers First End-to-End Study Startup Platform for Clinical Trials

Industry leader in clinical study startup releases site selection solution

SAN FRANCISCO, March 31, 2016 -- goBalto, Inc., the leading provider of cloud-based clinical study startup solutions, announced today its release of goBalto Select, for optimizing site selection. With this release, goBalto becomes the first life science software vendor to offer a complete end-to-end platform for starting clinical trials, from site feasibility assessment and selection through to activation, with comprehensive metrics to track adherence to timelines and budget.

March 22, 2016

goBalto Named Clinical Research and Excellence Awards Finalist

Awards recognize goBalto's Activate in the 'Best Sponsor-Focused Technological Development' category

SAN FRANCISCO, March 22, 2016 -- goBalto, Inc., the leading provider of cloud-based clinical study startup solutions, has been named a finalist in the 'Best Sponsor-Focused Technological Development' category for the 2016 Clinical Research & Excellence (CARE) Awards. Activate, a SaaS solution for accelerating site activation, a perpetual bottleneck in starting clinical trials, has been shortlisted for the inaugural awards, which take place in Boston on April 27, 2016.

March 08, 2016

goBalto Partners with Metrics Champion Consortium to Define Benchmarking Metrics for Study Startup

Industry leader in clinical study startup leverages metrics driven approach to deliver operational performance

SAN FRANCISCO, March 8, 2016 -- goBalto, Inc., the leading provider of cloud-based clinical study startup solutions, announced today its partnership with the Metrics Champion Consortium (MCC) as they join MCC's Leadership program. As a member of the Leadership Group, goBalto and the Metrics Champion Consortium member organizations will collaborate to define industry benchmark measures for Life Science organizations engaged in starting clinical trials.

February 18, 2016

goBalto Named Cloud Trailblazer in Annual Trailblazers Awards

Selected for bringing significant technological innovation to the startup stages in clinical trials

SAN FRANCISCO, February 18, 2016 -- goBalto, Inc., the leading provider of cloud-based clinical study startup solutions, has been announced as a winning Cloud Trailblazer in the 2015 Tech Trailblazers Awards. This distinction is in recognition of goBalto's purpose-built SaaS platform for starting clinical trials, which tracks milestones on the critical path, and provides document workflow management capabilities in a transparent, regulatory-compliant, and user-friendly way.

December 09, 2015

goBalto Activate chosen by ICON for Global Site Activation, Automation and Process Improvement

ICON implements Activate to accelerate study startup by reducing manual processes

SAN FRANCISCO, December 9, 2015 -- goBalto, Inc., the leading provider of cloud-based clinical study startup solutions, announced today that ICON has chosen goBalto to further bolster ICON's clinical study startup process on a worldwide basis.

November 12, 2015

Global Study Startup Survey Reveals Majority of Life Science Companies Lack Automated Processes

Industry leaders are adopting 'best of breed' applications in eClinical stack to speed clinical trials

SAN FRANCISCO, November 12, 2015 -- Preliminary findings from the goBalto, Inc. 2015 Global Study Startup Survey uncovered significant gaps in the industry's ability to efficiently manage document workflows and activities associated with starting clinical trials.

October 20, 2015

New European Clinical Trial Regulations aim to Reduce Administrative Burden and Costs

Industry leader in clinical study startup announces harmonized workflows for clinical trial expediency and compliance

SAN FRANCISCO, October 20, 2015 -- goBalto, Inc., the leading provider of cloud-based clinical study startup solutions, announced today compliance with new European regulatory directives aimed at creating an environment that is favorable for conducting clinical trials across the European Union.

October 06, 2015

Accelerating Clinical Trial Startup with Latest goBalto Activate Release

Industry leader in clinical study startup adds robust team management and submission planning features

SAN FRANCISCO, October 6, 2015 -- goBalto, Inc., the leading provider of cloud-based clinical study startup solutions, announced today its latest version of goBalto Activate. The third major release of 2015 offers new features that further accelerate clinical study startup.

September 08, 2015

goBalto joins Society for Clinical Research Sites as Global Impact Partner

Partnership bolsters collaboration with clinical research sites

SAN FRANCISCO, September 8, 2015 -- goBalto, Inc., the leading provider of cloud-based clinical study startup solutions, announced today a two-year partnership with the Society for Clinical Research Sites (SCRS), the globe trade organization fully dedicated to representing the interests of clinical research sites. Under the agreement, goBalto will participate as a Global Impact Partner (GIP), a relationship designed to facilitate critical dialogue between industry stakeholders and clinical research sites.

July 07, 2015

New Release of goBalto Activate Enhances Risk Management in Clinical Trials

Industry standard in clinical study startup adds robust project management and business optimization features

SAN FRANCISCO, July 7, 2015 -- goBalto, Inc., the leading provider of cloud-based clinical study startup solutions, announced today its latest version of goBalto Activate. The second major release of 2015 offers new features that further accelerate clinical study startup.

July 01, 2015

goBalto Triples Sites Managed, Further Reinforcing Market Leadership Position

Rapid adoption of award winning study startup solutions drive market penetration in Life Sciences industry

SAN FRANCISCO, July 1, 2015 -- goBalto, Inc., the leading provider of cloud-based clinical study startup solutions, announced today unprecedented growth in serving pharmaceutical, biotech and CRO companies.

June 11, 2015

Gartner Names goBalto a 2015 "Cool Vendor in Life Sciences"

Vendors selected for the "Cool Vendor" report are innovative, impactful and intriguing

SAN FRANCISCO, June 11, 2015 -- goBalto, Inc., the leading provider of cloud-based clinical study startup solutions, announced today that the company has been included in the Cool Vendors in Life Sciences, 2015 report, published by Gartner, Inc.

May 21, 2015

Moving Beyond Simple APIs in the eClinical Stack

True integration is critical to plug and play coexistence

SAN FRANCISCO, May 21, 2015 -- goBalto, Inc., the leading provider of cloud-based clinical study startup solutions, announced today that the company is the only non-TMF vendor to have released a fully integrated framework based on the new DIA TMF reference model (version 3.0) XML-based exchange mechanism.

March 23, 2015

New goBalto Activate Solution Further Accelerates Clinical Studies

Global pharma companies and CROs use goBalto to shorten clinical study startup

SAN FRANCISCO, March 23, 2015 -- goBalto, Inc., the leading provider of cloud-based clinical study startupsolutions, today announced its latest version of goBalto Activate. This first major release of 2015 offers new features that further accelerate clinical study startup.

January 21, 2015

goBalto Raises $12 million from Mitsui Global Investment and Dolby Family Ventures

goBalto solutions viewed as saving or improving the lives of global populations

SAN FRANCISCO - January 21, 2015 – goBalto, Inc., the leading provider of cloud-based clinical study startup solutions, announced today that it secured $12 million in funding from Mitsui Global Investment and Dolby Family Ventures. These new backers join goBalto’s roster of leading strategic partners, which includes Aberdare Ventures, EDBI, Qualcomm Life, and West Health Investment Fund.

January 13, 2015

goBalto Announces Latest Release of goBalto Activate

Over half of top 30 pharma and world’s largest CROs now using Activate worldwide

SAN FRANCISCO - January 13, 2015 – goBalto, Inc., the leading provider of cloud-based clinical study startup solutions, today announced the release of its latest version of goBalto Activate, its flagship study startup platform. With this release, goBalto is changing the way clinical study sponsors and contract research organizations (CROs) start clinical studies around the world.

November 25, 2014

goBalto Selected as a 2014 Red Herring Top 100 Global Company

Company joins elite group of innovative global entrepreneurs

SAN FRANCISCO - November 25, 2014 – goBalto, Inc., the leading provider of cloud-based clinical study startup solutions, has been recognized as a winner of Red Herring’s Top 100 Global award. goBalto also received a Global Top 100 North America award in 2013, marking its emergence as a top player in the international technology landscape.

November 18, 2014

goBalto Analyze Provides Advanced Clinical Study Startup Reporting

New product aims to give CROs and sponsors a competitive advantage

SAN FRANCISCO - November 18, 2014 – goBalto, Inc., the leading provider of cloud-based clinical study startup solutions, announced today the release of Analyze, a reporting tool that provides a real-time view into clinical operations data.

March 13, 2014

goBalto, Inc. Releases New Enhancements to Address Continued Market Momentum

Novartis Improves Cycle Times and Gains Process Efficiencies

SAN FRANCISCO - March 13, 2014 – goBalto, Inc., the leading provider of cloud-based clinical study startup solutions, announced today updates to its signature software platform. Key enhancements include additional global configuration support and new integration capabilities for smooth enterprise implementation.

January 08, 2014

goBalto, Inc. Expands Internationally

SAN FRANCISCO - January 8, 2014 – goBalto, Inc., the leading provider of clinical study startup solutions, today opens its first international locations in Singapore and the United Kingdom.

December 04, 2013

goBalto, Inc. Names Sujay Jadhav as Its New CEO

SAN FRANCISCO - December 4, 2013 – goBalto, Inc. announced today the appointment of Sujay Jadhav as Chief Executive Officer. Jae Chung, former CEO and founder, will manage corporate strategy, sales, and business development as President.

October 29, 2013

goBalto, Inc. Expands Tracker 2.0’s Analytics and Submissions Features

SAN FRANCISCO - October 29, 2013 – goBalto, Inc. announced today that the latest release of its signature product, Tracker 2.0, is now available.

June 21, 2013

goBalto, Inc. Creates Customer Success Division

SAN FRANCISCO - June 21, 2013 – goBalto, Inc. announced today its new Customer Success division, designed to nurture and expand customer relationships through world-class consultative account management practices, and to ensure continuous customer enthusiasm.

May 14, 2013

goBalto is a Finalist for the 2013 Red Herring Top 100 North America Award

SAN FRANCISCO - 14MAY2013 – goBalto announced today it was selected as a finalist for Red Herring's Top 100 North America award, a prestigious list honoring the year’s most promising private technology ventures from the North American business region.

May 01, 2013

goBalto Adds Site Collaboration and File Upload to Tracker 2.0, the Web-Based Platform for Study Startup

Enhanced Functionality Adds Even Greater Efficiency

SAN FRANCISCO, May 1, 2013 /PRNewswire/ -- goBalto, Inc. released new file management and site collaboration capabilities in the latest version of Tracker 2.0, the company’s cloud-based solution that helps accelerate clinical trial startup.

January 14, 2013

First-of-Its-Kind Benchmark Study on Investigative Site Initiation Process Published in Therapeutic Innovation & Regulatory Science

SAN FRANCISCO, Jan. 15, 2013 /PRNewswire/ -- goBalto, Inc. announced today the publication of 'Benchmarking the Study Initiation Process' in the January 2013 issue of the Therapeutic Innovation & Regulatory Science journal (formally called the 'Drug Information Journal' published by DIA), a study conducted in collaboration with the Tufts Center for the Study of Drug Development (CSDD).

January 08, 2013

INC Research Partners with goBalto™ to Further Enhance Clinical Study Startup Solution

San Francisco, Jan 8, 2013, /PRNewswire/ -- goBalto, Inc., a developer of new-generation web clinical research solutions, today announced that INC Research, a therapeutically-focused clinical research organization (CRO), has selected goBalto Tracker 2.0 as its global site activation solution. Tracker is a secure, web-based platform that enables study teams to track and manage site activation activities in clinical trials.

December 27, 2012

goBalto™ Raises $12 Million in Series B Financing from EDBI and Qualcomm Ventures

SAN FRANCISCO, Dec. 27, 2012 /PRNewswire/ -- goBalto, Inc. (www.gobalto.com) announced today that it closed a $12 million round of venture financing, led by EDBI, the global investment arm of Singapore's Economic Development Board, with participation from new investor Qualcomm Life Fund, a $100 million investment allocation that is managed by Qualcomm Ventures, Qualcomm's investment group. This round includes existing investors Aberdare Ventures, West Health Investment Fund, and Founding CEO Jae Chung. The new round of funding brings goBalto's total financing to $21 million.

October 11, 2012

goBalto to be a Host Company for Inaugural OpenCoSF Conference

San Francisco, October 11, 2012 /PRNewswire/ -- goBalto, Inc., a developer of new-generation web-based clinical research solutions, announced that it will participate as a host company for the inaugural OpenCoSF conference in San Francisco on Friday, October 12, 2012. Described as part conference and part festival, OpenCoSF is the place for innovative companies to share their visions and values while celebrating the collaborative ecosystem of the San Francisco Bay Area and Silicon Valley.

January 11, 2012

goBalto Completes a Successful FDA 21 CFR Part 11 Compliance Audit

SAN FRANCISCO, Jan. 11, 2012 /PRNewswire/ - goBalto, developer of new generation web-based clinical research solutions, announced that it successfully completed a FDA 21 CFR Part 11 compliance audit of its goBalto Tracker™ Software-as-a-Service (SaaS) clinical trials application. Tracker's successful audit will help both sponsors / clinical research organizations and investigator sites running clinical trials comply with FDA rules and regulations governing electronic records and electronic signatures.

November 17, 2011

goBalto Sponsors Tufts CSDD Study to Benchmark the Clinical Trial Initiation Process

Company Also Announces New Customer Genexion for Tracker™, its Web-based Clinical Research Platform

SAN FRANCISCO, November 17, 2011 /PRNewswire/ -- goBalto, developer of new generation web-based clinical research solutions, announced that it is providing a research grant for the Tufts Center for the Study of Drug Development (Tufts CSDD) to benchmark the clinical trial initiation process. Currently there is virtually no industry data available on the typical process that companies follow and on the amount of time that this process takes.

October 19, 2011

goBalto Raises Series A Financing to Advance Cloud-based Health Technologies

SAN FRANCISCO, October 19, 2011 /PRNewswire/ -- goBalto, developer of new generation web-based clinical research solutions, announced today that it has raised an undisclosed amount in Series A financing from Silicon Valley-based health technology investors Aberdare Ventures and the West Health Investment Fund. The funds will be used to expand goBalto's corporate activities and to enhance Tracker™, its Software-as-a-Service (SaaS) clinical trials platform that was launched in June 2011.

April 19, 2011

Silicon Valley Upstart, goBalto Launches Tracker Test Drive

30-Day Tryout Gives Users Full Access to the Software’s Features

San Francisco, CA - April 19, 2011 - Today goBalto announced a 30-day test drive of goBalto Tracker. Recently unveiled at the Partnerships in Clinical Trials conference, Tracker offers a new way for study managers and sites to start clinical trials directly from the web. The test drive is available by request. Due to a high volume of interest, test candidates are chosen based on whether they are about to start or are in the process of starting a study. The software will be available for purchase directly from goBalto’s website in June 2011. The Tracker test drive is fully functional for 30 days, and includes the ability to start and track a clinical trial directly from the web. After 30 days, users will be able to continue using Tracker by purchasing a monthly subscription.

March 31, 2011

goBalto Unveils Web Based Platform for Clinical Study Startup

goBalto introduces easier way to start clinical trials on the web

March 31, 2011 - SAN FRANCISCO, CA – From the 2011 Partnerships in Clinical Trials Conference, goBalto, today unveiled ‘Tracker’, an online platform to manage clinical study startup activities.

February 16, 2010

goBalto Drug Development Partnering Website Expands List of Clinical Investigative Sites

San Francisco, CA (PRWEB) February 16, 2010 -- goBalto, an online drug development partnering site for the pharmaceutical development and drug manufacturing industry, announced today a release of over 16,000 Clinical Sites, physicians and hospitals on goBalto.com. goBalto’s web-based platform enables members to quickly and efficiently find life-science service providers.

October 12, 2009

goBalto Introduces Web-based Solution to Manage Drug-development Collaborations

San Francisco, CA (PRWEB) October 12, 2009 -- goBalto, Inc. announced the release of 'Projects' for use within managing drug development and manufacturing projects. This builds on goBalto's past implementation of collaborative software for the pharmaceutical, biotech and contract service industries.

August 24, 2009

goBalto Drug Development Partnering WebSite to Include Clinical Trials Support’s List of Investigator Sites

Over 950 Latin American-based Investigator Sites Now Available on goBalto.com

SAN FRANCISCO, CA – August 24, 2009 – goBalto, an online drug development partnering site for the pharmaceutical development and drug manufacturing industry, announced today that Clinical Trials Support is making its proprietary list of over 950 Latin American-based Investigator Sites and hospitals available on goBalto.com. goBalto’s web-based platform enables members to quickly and efficiently find partners, share knowledge and discover opportunities.

July 21, 2009

goBalto Secures $500,000 in Series B Angel Funding

goBalto.com receives funding from three drug development industry veterans

San Francisco, CA – July 21, 2009 – goBalto, Inc. announced today that it has secured $500,000 in series B angel funding from several drug development industry veterans including Dr. Cary Queen, Dr. Donald Gerson and goBalto founder Jae Chung.

July 21, 2009

PharmaView: Pharma CMOs, Meet Web 2.0

How do you rate? With goBalto, your clients can tell all.

One of the virtues of the Internet age is that you need never shop uninformed. In the market for a car? Educate on Edmunds. An electrician? Angie’s List. A book, a board game? Ask Amazon.

June 23, 2009

goBalto Partners with Pharma Services Network to Help Sponsors Evaluate Leading CROs

Leading CROs Now Available on goBalto.com

SAN FRANCISCO, CA – June 23, 2009 – goBalto, a professional social networking site for the pharmaceutical development and drug manufacturing industry, announced today that Pharma Services Network is making its proprietary list of Clinical Research Organizations (CROs) available on goBalto.com.

May 19, 2009

goBalto Partners with Maya Clinicals to Expand Its List of Investigator Sites

Leading India-based Investigator Sites Now Available on goBalto.com

SAN FRANCISCO, CA – May 19, 2009 – goBalto, an online drug development partnering site for the pharmaceutical development and drug manufacturing industry, announced today that Maya Clinicals is making its proprietary list of India-based Investigator Sites and hospitals available on goBalto.com.

April 30, 2009

goBalto Partners with ChinaBio to Expand its list of Contract Research Organizations

Over 260 China-based Contract Research Organizations and Contract Manufacturing Organizations Now Available on goBalto.com

SAN FRANCISCO, CA – April 30, 2009 – goBalto, an online drug development partnering site for the pharmaceutical development and drug manufacturing industry, announced today that ChinaBio LLC is making its proprietary list of over 260 China-based Contract Research Organizations (CROs) and Contract Manufacturing Organizations (CMOs) available on goBalto.com. goBalto recently launched their web-based platform that enables members to quickly and efficiently find partners, share knowledge and discover opportunities.

April 15, 2009

Contract Drug Development Resource, goBalto, Launches New Web-Based Platform, goBalto.com

goBalto establishes new online platform to help pharmaceutical companies find, evaluate and manage drug partners from around the world, reducing inefficiencies in the drug development lifecycle

SAN FRANCISCO, CA – April 21, 2009 (PR Newswire) – goBalto, an online drug development partnering site for the pharmaceutical development and drug manufacturing industry, announced today its new platform and website, goBalto.com. goBalto transforms the way drug-development partners are matched. The web-based platform enables members to quickly and efficiently find partners, share knowledge, and discover opportunities.

Load More